1-150460153-G-A
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The ENST00000369068.5(RPRD2):c.1247G>A(p.Cys416Tyr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000137 in 1,461,694 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. C416R) has been classified as Uncertain significance.
Frequency
Consequence
ENST00000369068.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
RPRD2 | NM_015203.5 | c.1247G>A | p.Cys416Tyr | missense_variant | 9/11 | ENST00000369068.5 | NP_056018.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
RPRD2 | ENST00000369068.5 | c.1247G>A | p.Cys416Tyr | missense_variant | 9/11 | 1 | NM_015203.5 | ENSP00000358064 | P5 | |
RPRD2 | ENST00000401000.8 | c.1169G>A | p.Cys390Tyr | missense_variant | 8/10 | 1 | ENSP00000383785 | A2 | ||
RPRD2 | ENST00000492220.1 | n.1419G>A | non_coding_transcript_exon_variant | 9/11 | 5 |
Frequencies
GnomAD3 genomes Cov.: 31
GnomAD3 exomes AF: 0.00000401 AC: 1AN: 249156Hom.: 0 AF XY: 0.00000740 AC XY: 1AN XY: 135170
GnomAD4 exome AF: 0.00000137 AC: 2AN: 1461694Hom.: 0 Cov.: 32 AF XY: 0.00000138 AC XY: 1AN XY: 727130
GnomAD4 genome Cov.: 31
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 12, 2022 | The c.1247G>A (p.C416Y) alteration is located in exon 9 (coding exon 9) of the RPRD2 gene. This alteration results from a G to A substitution at nucleotide position 1247, causing the cysteine (C) at amino acid position 416 to be replaced by a tyrosine (Y). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at